Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis
El Raziky, M., Gamil, M., Ashour, M. K., Sameea, E. A., Doss, W., Hamada, Y., Van Dooren, G., DeMasi, R., Keim, S., Lonjon‐Domanec, I., Hammad, R., Hashim, M. S., Hassany, M., Waked, I.
Published in Journal of viral hepatitis (01.02.2017)
Published in Journal of viral hepatitis (01.02.2017)
Get full text
Journal Article
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
Colombo, M, Fernández, I, Abdurakhmanov, D, Ferreira, P A, Strasser, S I, Urbanek, P, Moreno, C, Streinu-Cercel, A, Verheyen, A, Iraqi, W, DeMasi, R, Hill, A, Läuffer, J M, Lonjon-Domanec, I, Wedemeyer, H
Published in Gut (01.07.2014)
Published in Gut (01.07.2014)
Get full text
Journal Article
Low rate of drug-drug interaction management during interferon-free simeprevir therapy – an integrated analysis of interventional and observational clinical studies
Marra, F, Höner zu Siederdissen, C, Khoo, S, Cornberg, M, Schlag, M, Ouwerkerk-Mahadevan, S, Bicer, C, Lonjon-Domanec, I, Jessner, W, Beumont-Mauviel, M, Kalmeijer, R, Back, D
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis
Hezode, C, Almasio, P, Bourgeois, S, Buggisch, P, Brown, A, Diago, M, Horsmans, Y, Serfaty, L, Szalay, F, Gaeta, G.B, Planas, R, Schlag, M, Lonjon-Domanec, I, Gilles, L, DeMasi, R, Zeuzem, S
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
P1208 PREDICTION OF SEVERE CUTANEOUS REACTION DURING TRIPLE THERAPY IN HCV: VALIDATION OF A GWAS CANDIDATE GENETIC MARKER
Palescandolo, E, Vijgen, L, Talloen, W, Colombo, M, Mangia, A, Wedemeyer, H, Demasi, R, Lonjon-Domanec, I, Aerssens, J
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P0792 : Baseline factors associated with increased SVR rates in 123 treatment-naïve chronic HCV genotype 1 patients treated with a shortened 12-week simeprevir plus pegylated interferon and ribavirin regimen: a multivariate analysis
Asselah, T, Moreno, C, Sarrazin, C, Gschwantler, M, Foster, G.R, Craxi, A, Buggisch, P, Ryan, R, Lenz, O, Van Dooren, G, Lonjon-Domanec, I, Schlag, M, Buti, M
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P1346 : Study protocol for a partly randomised, open-label phase IIA trial of once-daily simeprevir combined with sofosbuvir for the treatment of HCV genotype 4 infected patients with or without cirrhosis (OSIRIS)
El Raziky, M, Gamil, M, Hammad, R, Hashem, M.S, Hassany, M, Khairy, M, El Sharkawy, A, Gomaa, A, Keim, S, Van Dooren, G, DeMasi, R, Lonjon-Domanec, I, Doss, W, Waked, I
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P1210 PREDICTORS OF SVR24 FOR 1078 PATIENTS WITH SEVERE FIBROSIS OR COMPENSATED CIRRHOSIS: THE INTERNATIONAL TELAPREVIR ACCESS PROGRAM
Colombo, M, Strasser, S.I, Moreno, C, Ferreira, P.A, Urbanek, P, Fernández, I, Abdurakhmanov, D, Streinu-Cercel, A, Verheyen, A, Iraqi, W, Demasi, R, Hill, A, Lonjon-Domanec, I, Wedemeyer, H
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1212 USE OF BASELINE FIBROSCAN TO PREDICT EFFICACY AND SAFETY OF TREATMENT FOR 1143 PATIENTS IN THE TELAPREVIR EARLY ACCESS PROGRAMME
Wedemeyer, H, Colombo, M, Strasser, S.I, Ferreira, P.A, Urbanek, P, Fernandez, I, Abdurakhmanov, D, Streinu-Cercel, A, Beeldens, F, Iraqi, W, Demasi, R, Hill, A, Lonjon-Domanec, I, Moreno, C
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1206 ITPA GENE VARIANTS AND ANEMIA DURING TELAPREVIR/PEGINTERFERON/RIBAVIRIN COMBINATION THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
Tuefferd, M, Palescandolo, E, Vijgen, L, Colombo, M, Roberts, S, Wedemeyer, H, Zeuzem, S, De Meyer, S, Demasi, R, Witek, J, Lonjon-Domanec, I, Aerssens, J
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
806 MANAGEMENT AND OUTCOMES OF ANEMIA IN THE INTERNATIONAL TELAPREVIR EARLY ACCESS PROGRAM, FOR PATIENTS WITH HEPATITIS C GENOTYPE 1 INFECTION
Colombo, M, Fernández, I, Abdurakhmanov, D, Ferreira, P.A, Strasser, S, Urbanek, P, Moreno, C, Streinu-Cercel, A, Beeldens, F, Iraqi, W, DeMasi, R, Hill, A, Läuffer, J.M, Lonjon-Domanec, I, Wedemeyer, H
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
1117 TELAPREVIR FRENCH COHORT AUTHORIZATION FOR TEMPORARY USE IN GENOTYPE 1 HEPATITIS C CIRRHOTIC PATIENTS WITH PRIOR PARTIAL RESPONSE OR RELAPSE
Hadacek, B, Danton, A.-C, Barbé, N, Masson, F, Quélard, D, Naessens, D, Picchio, G, Witek, J, Lonjon-Domanec, I, Miara, A
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
6 SUBANALYSES OF THE TELAPREVIR LEAD-IN ARM IN THE REALIZE STUDY: RESPONSE AT WEEK 4 IS NOT A SUBSTITUTE FOR PRIOR NULL RESPONSE CATEGORIZATION
Foster, G.R, Zeuzem, S, Andreone, P, Pol, S, Lawitz, E.J, Diago, M, Roberts, S, Pockros, P.J, Younossi, Z, Lonjon-Domanec, I, Van Heeswijk, R, de Meyer, S, Luo, D, George, S, Beumont, M, Picchio, G
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
T-29 Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III REALIZE study
Andreone, P, Berg, T, Pol, S, Roberts, S, Younossi, Z, Diago, M, Lawitz, E.J, Focaccia, R, Foster, G.R, Horban, A, Lonjon-Domanec, I, DeMasi, R, Picchio, G, Witek, J, Zeuzem, S
Published in Digestive and liver disease (01.02.2012)
Published in Digestive and liver disease (01.02.2012)
Get full text
Journal Article
T-26 Impact of anemia and ribavirin dose reduction on SVR to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure in the Phase III REALIZE study
Andreone, P, Roberts, S, Pol, S, Younossi, Z, Diago, M, Lawitz, E.J, Focaccia, R, Foster, G.R, Horban, A, Lonjon-Domanec, I, DeMasi, R, Van Heeswijk, R, Picchio, G, Witek, J, Zeuzem, S
Published in Digestive and liver disease (01.02.2012)
Published in Digestive and liver disease (01.02.2012)
Get full text
Journal Article
T-25 Impact of insulin resistance on antiviral efficacy of telaprevir-based regimen in treatment-naïve genotype 1 HCV: Results from C208 sub-analysis
Carosi, G, Colombo, M, Spinetti, A, Zaltron, S, Serfaty, L, Marcellin, P, Lonjon-Domanec, I, DeMasi, R, Beumont, M
Published in Digestive and liver disease (2011)
Published in Digestive and liver disease (2011)
Get full text
Journal Article
T-28 Impact of insulin resistance on virologic response to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: post-hoc analysis of the REALIZE Phase III study
Andreone, P, Younossi, Z, Negro, F, Serfaty, L, Pol, S, Diago, M, Zeuzem, S, Lawitz, E.J, Roberts, S, Focaccia, R, Foster, G.R, Horban, A, Lonjon-Domanec, I, Coate, B, DeMasi, R, Picchio, G, Witek, J
Published in Digestive and liver disease (01.02.2012)
Published in Digestive and liver disease (01.02.2012)
Get full text
Journal Article
T-27 Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study
Andreone, P, Pol, S, Roberts, S, Younossi, Z, Diago, M, Lawitz, E.J, Focaccia, R, Foster, G.R, Horban, A, Lonjon-Domanec, I, DeMasi, R, Van Heeswijk, R, DeMeyer, S, Picchio, G, Witek, J, Zeuzem, S
Published in Digestive and liver disease (01.02.2012)
Published in Digestive and liver disease (01.02.2012)
Get full text
Journal Article
833 LIVER FIBROSIS ASSESSMENT IN CHRONIC HEPATITIS C: EVOLUTION OF CLINICAL PRACTICE IN A LARGE COHORT OF 4546 PATIENTS BETWEEN 2003 AND 2006
Roudot-Thoraval, F, Ouzan, D, Denis, J, Guyader, D, Doffoel, M, Delasalle, P, Abergel, A, Marcellin, P, Chousterman, M, Hayem, C, Lonjon-Domanec, I, Bourliere, M
Published in Journal of hepatology (2008)
Published in Journal of hepatology (2008)
Get full text
Journal Article